MedTrace Logo

Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily

NCT03067415 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2017-07-21

No results posted yet for this study

Summary

Exploratory trial to evaluate the efficacy and safety of D565H twice daily versus D565 once daily.

Conditions

Interventions

DRUG

D565H(Latanoprost 25㎍/㎖)

D565H twice daily

DRUG

D565(Latanoprost 50㎍/㎖)

D565 once daily

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • KiHo Park · Seoul National University Hosipital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-30
Primary Completion
2017-09-10
Completion
2017-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03067415 on ClinicalTrials.gov